SCHEMBL6562162

SCHEMBL6562162

COc1ccc(C(=O)Cc2cccc[n+]2C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.53
NPC1 O15118 7/20 0.50
RAB9A P51151 4/20 0.50
GSK3B P49841 1/20 0.49
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC11 Q96DB2 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
HDAC9 Q9UKV0 1/20 0.49
HDAC5 Q9UQL6 1/20 0.49
LMNA P02545 2/20 0.47
KDM4E B2RXH2 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HSD11B1 P28845 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL5949446 0.99 KMT2A (0.52) KMT2ANPC1RAB9AGSK3BHDAC3
SCHEMBL6342190 0.91 KMT2A (0.46) KMT2ANPC1RAB9AGSK3BHDAC3
SCHEMBL11619439 0.84 KMT2A (0.52) KMT2ANPC1RAB9AGSK3BHDAC3
SCHEMBL6562435 0.83 NPC1 (0.50) KMT2ANPC1RAB9AGSK3BLMNA
SCHEMBL6561313 0.82 CES2 (0.54) KMT2ANPC1RAB9AGSK3BHDAC3
SCHEMBL6561361 0.82 L3MBTL1 (0.54) KMT2ANPC1RAB9AGSK3BLMNA
SCHEMBL2562144 0.82 SMN1; SMN2 (0.47) KMT2ANPC1RAB9AGSK3BHDAC3
Iodide SCHEMBL5949437 0.82 NPC1 (0.49) KMT2ANPC1RAB9AGSK3BLMNA
Iodide SCHEMBL5949248 0.81 CES2 (0.53) KMT2ANPC1RAB9AGSK3BHDAC3
Iodide SCHEMBL5949473 0.81 L3MBTL1 (0.53) KMT2ANPC1RAB9AGSK3BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1050531-B1 Pyridine and piperidine derivatives for treating neurodegenerative diseases SERVIER LAB (FR) 2004-11-17 EP disclosed
EP-1050531-A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases ADIR ET COMPAGNIE (FR) 2000-11-08 EP disclosed